Literature DB >> 34787781

Development of a Purified Viral Preparation for Studies of COVID-19 (SARS-CoV-2) Biology.

A A Chepurnov1, E I Kazachinskaya2, E A Kazachkova2, K A Sharshov2, Yu V Kononova2, A A Shelemba2, A Yu Alekseev2, M A Gulyeva2, M I Voevoda2, A M Shestopalov2.   

Abstract

Different methods for producing bulk quantities of concentrated and purified SARS-CoV-2 for the use as antigens and for the research into COVID-19 biology were tested.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  2002 year SARS-CoV; SARS-CoV-2; electrophoresis; purified virus preparations

Mesh：

Substances：

Year:  2021        PMID： 34787781      PMCID： PMC8596366          DOI： 10.1007/s10517-021-05329-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  13 in total

1.  [Titration of Ebola and Marburg viruses by plaque formation under semi liquid agar].

Authors:  E N Ustinova; A M Shestopalov; L F Bakulina; A A Chepurnov
Journal:  Vopr Virusol       Date:  2003 Jan-Feb

2.  [Isolation of purified Ebola virus].

Authors:  A A Chepurov; N V Merzlikin; E I Rabchikova; T S Chepurnova; V E Volchkov; N N Istomina; V A Kuz'min; M S Vorob'eva
Journal:  Vopr Virusol       Date:  1994 Nov-Dec

3.  Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model.

Authors:  Tarek Hamouda; Alexander Chepurnov; Nicholas Mank; Jessica Knowlton; Tatiana Chepurnova; Andrzej Myc; Joyce Sutcliffe; James R Baker
Journal:  Hum Vaccin       Date:  2010-07

4.  Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Protein in the Ocular Tissues of a Patient Previously Infected With Coronavirus Disease 2019.

Authors:  Ying Yan; Bo Diao; Yueping Liu; Wenqiang Zhang; Gang Wang; Xiao Chen
Journal:  JAMA Ophthalmol       Date:  2020-11-01       Impact factor: 7.389

5.  Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein.

Authors:  A A Chepurnov; M N Tuzova; V A Ternovoy; I V Chernukhin
Journal:  Immunol Lett       Date:  1999-06-01       Impact factor: 3.685

6.  Inactivation of Ebola virus with a surfactant nanoemulsion.

Authors:  A A Chepurnov; L F Bakulina; A A Dadaeva; E N Ustinova; T S Chepurnova; J R Baker
Journal:  Acta Trop       Date:  2003-08       Impact factor: 3.112

7.  Purification and electron cryomicroscopy of coronavirus particles.

Authors:  Benjamin W Neuman; Brian D Adair; Mark Yeager; Michael J Buchmeier
Journal:  Methods Mol Biol       Date:  2008

8.  Purification of coronavirus virions for Cryo-EM and proteomic analysis.

Authors:  Stuart Dent; Benjamin W Neuman
Journal:  Methods Mol Biol       Date:  2015

9.  Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs.

Authors:  A A Chepurnov; A A Dadaeva; E M Malkova; S I Kolesnikov; L S Sandakhchiev
Journal:  Dokl Biol Sci       Date:  2004 Jul-Aug

10.  Development of an inactivated vaccine candidate for SARS-CoV-2.

Authors:  Qiang Gao; Linlin Bao; Haiyan Mao; Lin Wang; Kangwei Xu; Minnan Yang; Yajing Li; Ling Zhu; Nan Wang; Zhe Lv; Hong Gao; Xiaoqin Ge; Biao Kan; Yaling Hu; Jiangning Liu; Fang Cai; Deyu Jiang; Yanhui Yin; Chengfeng Qin; Jing Li; Xuejie Gong; Xiuyu Lou; Wen Shi; Dongdong Wu; Hengming Zhang; Lang Zhu; Wei Deng; Yurong Li; Jinxing Lu; Changgui Li; Xiangxi Wang; Weidong Yin; Yanjun Zhang; Chuan Qin
Journal:  Science       Date:  2020-05-06       Impact factor: 47.728
View more
  1 in total

1.  Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?

Authors:  Iuliia A Merkuleva; Dmitry N Shcherbakov; Mariya B Borgoyakova; Anastasiya A Isaeva; Valentina S Nesmeyanova; Natalia V Volkova; Vazirbek S Aripov; Daniil V Shanshin; Larisa I Karpenko; Svetlana V Belenkaya; Elena I Kazachinskaia; Ekaterina A Volosnikova; Tatiana I Esina; Alexandr A Sergeev; Kseniia A Titova; Yulia V Konyakhina; Anna V Zaykovskaya; Oleg V Pyankov; Evgeniia A Kolosova; Olesya E Viktorina; Arseniya A Shelemba; Andrey P Rudometov; Alexander A Ilyichev
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.